Consistent with our results, GPX4 dependency of DTP cells induced by targeted TKI has also been found in HER2‐amplified breast cancer, EGFR‐mutated NSCLC, and BRAF‐mutated melanoma [10]. Here, GPX4 is linked to breast carcinoma.